P45: Began Phase II trial

Previously reported interim 20-week results from a separate U.K. 52-week Phase II trial of P45

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE